TuneLab Connect - September 24, 2026
|
Access Lilly TuneLab Models: Federated AI for Smarter Drug Discovery
What if your team could access Lilly-developed AI models for small-molecule and antibody property prediction, while securely contributing to and benefiting from continuously improving federated models?
- Access high-value AI models: leverage Lilly TuneLab models for Small Molecule and Antibody property predictions, directly usable in your discovery workflows
- Operationalize AI across teams: TuneLab predictions are directly at hand for chemists and biologists in their research context within Signals secure cloud environment and the new software Signals Xynthetica for delivering Models-as-a-Service.
- Contribute and benefit from federated learning: share data securely, improve global model performance, and accelerate decision-making without compromising IP
Join us to explore how startups and biotechs can move from isolated models to scalable, collaborative AI that drives real impact in your drug discovery programs.

